Clinical trials
Phase 1 Kidney Neoplasms trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
136 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 8 |
| 2001 | 5 |
| 2002 | 5 |
| 2003 | 1 |
| 2004 | 3 |
| 2005 | 9 |
| 2006 | 11 |
| 2007 | 7 |
| 2008 | 5 |
| 2009 | 9 |
| 2010 | 3 |
| 2011 | 3 |
| 2012 | 3 |
| 2013 | 1 |
| 2014 | 5 |
| 2015 | 6 |
| 2016 | 6 |
| 2017 | 5 |
| 2018 | 5 |
| 2019 | 2 |
| 2020 | 3 |
| 2022 | 4 |
| 2023 | 3 |
| 2024 | 4 |
| 2025 | 3 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 91 |
| Terminated | 20 |
| Recruiting | 13 |
| Active, not recruiting | 7 |
| Withdrawn | 3 |
| Not yet recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 15 |
| Memorial Sloan Kettering Cancer Center | 9 |
| National Institutes of Health Clinical Center (CC) | 6 |
| Masonic Cancer Center, University of Minnesota | 5 |
| Astellas Pharma Inc | 4 |
| Bristol-Myers Squibb | 4 |
| Celldex Therapeutics | 4 |
| Northwestern University | 3 |
| Novartis Pharmaceuticals | 3 |
| Pfizer | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Kidney Neoplasms | 136 |
| Carcinoma, Renal Cell | 77 |
| Lung Neoplasms | 40 |
| Breast Neoplasms | 39 |
| Carcinoma, Non-Small-Cell Lung | 35 |
| Ovarian Neoplasms | 33 |
| Colorectal Neoplasms | 32 |
| Melanoma | 31 |
| Neoplasms | 29 |
| Head and Neck Neoplasms | 24 |
Trials
Showing 1 to 25 of 136. Each trial links to its page on Pharma Observatory.
36 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.